INS and Hyperinsulinemia: Nevertheless, insulin signaling is impaired in LRP1 NPxY mutant hepatocytes and this mutation does not exacerbate or protect against HFHC diet-induced hyperglycemia, hyperinsulinemia, and insulin resistance.